“Substance+dependence”的搜索结果，显示 281-290 项，共有 3229 项

1. 血液科- 临床试验- 妙佑医疗国际

   ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization ...

2. 泌尿科- 临床试验- 妙佑医疗国际

   Currently, most drug-related cancer care is conducted in clinic type centers or hospitals which may isolate patients from family, friends and familiar ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma.

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Other preclincal models to test drug effcicacy includes ex vivo 3D culture and 2D culture systems. In this study, we make and test preclinical models of ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Other preclincal models to test drug effcicacy includes ex vivo 3D culture and 2D culture systems. In this study, we make and test preclinical models of ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

7. 泌尿科- 临床试验- 妙佑医疗国际

   Currently, most drug-related cancer care is conducted in clinic type centers or hospitals which may isolate patients from family, friends and familiar ...

8. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   Currently, most drug-related cancer care is conducted in clinic type centers or hospitals which may isolate patients from family, friends and familiar ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

10. 外科 - 临床试验- 妙佑医疗国际

    ... abuse potential. A Study of the Ability to Predict Lymphedema Development Following Axillary Surgery for Breast Cancer and Its Effects on Patient ...